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 Since the potential of stem cells (SCs) in treating diseases is superb, it is believed that the 
use of SCs is a promising therapeutic approach in hearing damage. More than 250 million 
people of worldwide are born deaf. The deaf hearing generally originate from defect on 
sensory receptors (hair cells) or nerves associated with them (spiral ganglion neurons). Hair 
cells in some animals such as fish, amphibians and birds can regenerate or replace by new 
cells, but damage to the hair cells in mammals are not being replaced through cell division 
or regeneration in the inner ear. Cell therapy for hearing loss is still several years away, but 
researches opens up possibilities for restoring hearing in the future. Here we review 
developments in cell therapy approach in treatment of hearing loss. 
Cite this article as: Ahmady Roozbahany N, Niknazar S. Cell Therapy Development in Hearing Loss. 2016; 2(2): 51-55. 
INTRODUCTION
Hearing loss is the most prevalent sensory 
defect. Hearing mainly depends on hair cells 
and their associated spiral ganglion neurons. 
Loss of hair cells and spiral ganglion neurons 
in the inner ear cause hearing loss in humans 
(1). At present, no effective treatment exists to 
repair the sensory structures in the inner ear. 
There is no precise treatment for sensorineural 
hearing loss. Only rehabilitation instruments 
such as hearing aids are used for approximate 
compensation of these disorders. However, in 
cases where hair cells are completely 
destroyed, cochlear implants may provide 
hearing (2). The main task of hair cells within 
the cochlea of the inner ear is conversion of 
mechanical vibrations of sound into electrical 
impulses that reach the brain through the 
auditory nerve (3).When mechanosensitive 
hair cells are damaged, an individual 
experiences a reduction or loss of hearing. 
Obviously, sometimes when the cause is 
eliminated, the cells rebuild and continue their 
activities, but in most cases there is no such 
possibility and hearing loss becomes 
permanent. Unlike hair cells in lower 
vertebrates such as birds and fish, auditory hair 
cells of mammalian do not spontaneously 
regenerate (4). 
Using SCs to generate hearing cells is a 
promising therapeutic strategy in cases with 
hearing damage. It has been discovered that 
SCs can differentiate to hair cells. In addition, 
new evidence in animal models indicates that 
suitable stimulation of SCs in the inner ear 
induce self-renewal and differentiation into 
auditory sensory cell (5). Advances in stem 
cell therapies may provide effective treatment 
for irreversible damage to auditory system. 
Researchers try to develop techniques to 
generate hair cells in the laboratory and graft 
them into the ear. In this review, the 
applications of SCs as treatment for hearing 
loss are discussed. 
 
STEM CELL APPLICATIONS 
In recent years, the potential therapeutic role 
of SCs has been considered in the treatment of 
various diseases such as diabetes, parkinson, 
alzheimer and cardiac diseases (6-9). By 
definition; SCs have the ability for self-
renewal, differentiation and the creation of 
other cell types addition to themselves (10). 
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The main differences between several groups 
of SCs are the source of 
 cells that can be obtained from them. There 
are two main types of SCs. The embryonic 
stem cells (ESC) exist in the blastocyst inner 
cell mass and the adult SCs that found in 
various types of tissue such as bone marrow 
and blood (11, 12). Recently, stem cell 
transplantation has been regarded for their 
repair activity in hair cells and auditory 
neurons damage. Transplanted cell, including 
adult stem cell and ESCs were survived for ten 
weeks after transplantation. Further research 
showed that implanted cells have the 
capability to match with the host auditory 
system structurally, and can even replace 
spiral ganglion neurons. As well, neuronal 
differentiation of implanted stem cell was 
reported previously (13, 14). 
 
GENERATION of HAIR CELLS 
FROM EMBRYONIC STEM CELLS 
Researchers have been attempting to convert 
SCs to the inner ear mechanosensitive hair 
cells and sensory neurons. Studies have been 
shown stepwise differentiation of sensory 
epithelia from murine ESCs (15, 16). Li. et al 
reported that inner-ear progenitors have been 
produced from mouse ESCs in the culture. 
These progenitors have marker genes that 
index them as hair cells (17). These ES-cell-
derived progenitors express Math1 (mouse 
atonal homolog 1) and Brn3.1, which have an 
important role in the generation and 
maturation of hair cells (18, 19). Koehler et al. 
have demonstrated that in vitro differentiation 
of hair cells from ESC possess stereocilia 
bundles and a kinocilium. Moreover, these 
stem-cell-derived hair cells have functional 
characteristics of natural inner ear hair cells 
and make synaptic connections with sensory 
neurons that have also originated from ESCs 
in vitro (16). Other experiments have revealed 
human embryonic SCs differentiated to inner 
ear hair cell-like cells in the optimized 
condition in culture (20). 
GENERATION of HAIR CELLS 
FROM ADULT STEM CELLS 
Today, adult SCs isolated from several tissues 
can be deployed for treatment approaches in 
the hearing defects. It is known that fibers 
regrow in the peripheral nervous system after 
tissue injury. Regrowth of olfactory neurons 
has been reported to occur spontaneously. In 
contrast, replacement of lost neural cells has 
rarely been demonstrated. Although there is 
little normal turnover in the central nervous 
system, cells can be recruited to replace lost 
neurons (21). 
Findings have shown that bone marrow 
mesenchymal stem cells (BMSCs) can 
differentiate into hair cells. Differentiated cells 
express hair cells markers and exhibit 
morphological properties of hair cells 
stereociliary bundles. Adult stem cells also 
have been used to deliver therapeutic 
molecules and gene to the  inner ear (22). 
 BMSCs also have the potential to produce 
auditory neurons in vitro and in vivo (23, 24). 
Adult SCs derived from the olfactory 
neuroepithelium has a differentiation potential 
to generate hair cells (25)  . Neural SCs survive 
in drug-injured mouse inner ear for several 
weeks after transplantation and exhibit 
markers of neuron and hair cell (26, 27). 
 
GENERATION of HAIR CELLS 
FROM ENDOGENOUS STEM CELLS 
One promising approach for the sensorineural 
hearing loss treatment includes activation of 
endogenous SCs or genetic targeting of 
surviving supporting cells (28).While several 
studies have demonstrated delivery and 
survival of ES and adult SCs in normal and 
damaged inner ear in vivo, in some cases, a 
therapeutic effect has been reported (29, 30). 
Few studies have revealed differentiation and 
regeneration of resident SCs. It has been 
shown resident SCs in the mouse utricle can be 
isolated and propagated in culture. In addition 
to the utricle in the vestibular system, cochlea 
in neonates has endogenous SCs (17, 31). 
Cell Therapy Development in Hearing Loss  53 
 
This open-access article distributed under the terms of the Creative Commons Attribution Non Commercial 3.0 License (CC BY-NC 3.0). 
Copyright © 2016 Shahid Beheshti University of Medical Sciences. All rights reserved. Downloaded from: www.journalhso.com  
 
Previous findings revealed that trans-
differentiation of supporting cells to hair cells 
could play a role in regeneration, but this 
ability was limited to neonatal mice and occurs 
on the first postnatal day. Molecular aspects 
such as Atho-1 expression and notch pathway 
inhibition have an important role in the 
conversion of supporting cell to hair cell (32, 
33). 
 
DO STEM CELL DERIVED HAIR 
CELL ARE FUNCTIONAL? 
Stem cell therapy is  effective in hearing loss 
when stem cell-derived progenitors 
differentiate to hair cells with appropriate 
morphology, electrical activity and capacity 
for appropriate innervations with target tissues 
(34). Indeed, stem cell-derived neurons ideally 
need to extend peripheral projections directed 
toward the sensory hair cells in the organ of 
corti, and toward neurons in the cochlear 
nucleus (35). Expression of synaptic markers 
such as synapsin1 and synaptophysin have 
been observed in the afferent dendrites of early 
postnatal auditory neurons when they reform 
their connections with hair cells in vitro (36, 
37).  Expression of synapsin1 was reported in 
neural stem cell -derived neurons at the nerve 
ending near the hair cells in co-culture models 
(38, 39) 
Therefore, the expression of synapsin1 is 
considered as an indicator of stem cell-derived 
auditory neurons capacity to regenerate or 
form potentially functional synapses with hair 
cells (40). Several previous studies have 
demonstrated that human ESC has the capacity 
to make new synapses with hair cells in the 
auditory system (38, 41).  Nayagam et al. have 
observed presynaptic formation between the 
peripheral projections of auditory neurons and 
hair cells in early postnatal cochlear explants 
cultures and adult cochlea (42). Recent in vivo 
studies reported that partial hearing function 
restore can be achieved following the 
transplantation of early stage human ESC-
derived otic neural progenitors into deafened 
gerbil cochleae (42, 43). 
 
CONCLUSION 
Stem cell based therapy is possible for 
restoring or replacing of hair cells. Generation 
of functional auditory hair cells is a main aim 
of stem cell researchers, but there are obstacles 
in this way, and it requires further studies on 
signaling cascades and molecular aspects 
involved in hair cell regeneration. 
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